Repros Therapeutics Inc.
News
Prudential PLC Acquires Shares of 123,524 Royalty Pharma plc (NASDAQ:RPRX)
Ticker Report Prudential PLC bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange...\n more…
Royalty Pharma (NASDAQ:RPRX) Stock Rating Lowered by StockNews.com
Ticker Report Royalty Pharma (NASDAQ:RPRX - Get Free Report) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued on Monday. Several other brokerages have...\n more…
RPRX Breaks Above 3% Yield Territory
Dividend Channel In trading on Tuesday, shares of Royalty Pharma plc (RPRX) were yielding above the 3% mark based on its quarterly dividend (annualized to 0.84), with the stock changing hands as low as...\n more…
Royalty Pharma plc (NASDAQ:RPRX) Given Average Recommendation of "Moderate Buy" by Brokerages
Zolmax Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) has been given an average recommendation of "Moderate Buy" by the five research firms that are covering the company, MarketBeat reports. One...\n more…
Royalty Pharma plc (NASDAQ:RPRX) Given Consensus Rating of "Moderate Buy" by Brokerages
Ticker Report Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) has received an average recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat reports. One research...\n more…
Ascendis and Royalty Pharma enter into $150M royalty funding agreement
SeekingAlpha.com: All News Ascendis Pharma and Royalty Pharma enter $150M royalty funding agreement for YORVIPATH based on U.S.\n more…